Your browser doesn't support javascript.
loading
COVID-19 vaccine uptake trends in SARS-CoV-2 previously infected cancer patients.
Shahid, Zainab; Patrick, Alicia L; Wallander, Michelle L; Donahue, Erin E; Trufan, Sally J; Tan, Antoinette R; Hwang, Jimmy J; Burgess, Earle F; Ragon, Brittany; Ghosh, Nilanjan; Grunwald, Michael R; Voorhees, Peter M; Copelan, Edward A; Raghavan, Derek.
Afiliação
  • Shahid Z; Department of Hematologic Malignancies and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, United States.
  • Patrick AL; LCI Clinical Research, Clinical Trials Office, Levine Cancer Institute, Atrium Health, Charlotte, NC, United States.
  • Wallander ML; LCI Clinical Research, Clinical Trials Office, Levine Cancer Institute, Atrium Health, Charlotte, NC, United States.
  • Donahue EE; Department of Biostatistics, Levine Cancer Institute, Atrium Health, Charlotte, NC, United States.
  • Trufan SJ; Department of Biostatistics, Levine Cancer Institute, Atrium Health, Charlotte, NC, United States.
  • Tan AR; Department of Solid Tumor Oncology and Investigational Therapeutics, Levine Cancer Institute, Atrium Health, Charlotte, NC, United States.
  • Hwang JJ; Department of Solid Tumor Oncology and Investigational Therapeutics, Levine Cancer Institute, Atrium Health, Charlotte, NC, United States.
  • Burgess EF; Department of Solid Tumor Oncology and Investigational Therapeutics, Levine Cancer Institute, Atrium Health, Charlotte, NC, United States.
  • Ragon B; Department of Hematologic Malignancies and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, United States.
  • Ghosh N; Department of Hematologic Malignancies and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, United States.
  • Grunwald MR; Department of Hematologic Malignancies and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, United States.
  • Voorhees PM; Department of Hematologic Malignancies and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, United States.
  • Copelan EA; Department of Hematologic Malignancies and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, United States.
  • Raghavan D; Levine Cancer Institute, Atrium Health, Charlotte, NC, United States.
Vaccine X ; 14: 100289, 2023 Aug.
Article em En | MEDLINE | ID: mdl-37020982
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Vaccine X Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Vaccine X Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos